AV Laboratories Appoints Dr. Dendy Engelman to Scientific Advisory Board
Dendy Engelman, M.D. • Photo Credit: AV Laboratories
NEW YORK, March 14, 2026 (WELLNESS INTERVIEWS) — Skincare company, AV Laboratories, a biotechnology-driven brand specializing in clinical longevity-focused skincare, has announced the appointment of Dr. Dendy Engelman, MD, FACMS, FAAD, to its Scientific Advisory Board.
Wellness Interviews
♾️
Wellness Interviews ♾️
Engelman is a board-certified dermatologist and Mohs surgeon based in New York City. She has experience in medical, cosmetic, and surgical dermatology, along with involvement in clinical research, physician education, and product development within the skincare and pharmaceutical industries.
In her role on the Scientific Advisory Board, Engelman will provide guidance on clinical strategy, product development, and scientific positioning as the company advances its biotechnology-powered skincare initiatives, according to AV Laboratories.
“Dr. Engelman represents the intersection of clinical excellence and future-forward dermatology. Her expertise and perspective will be invaluable as we continue to elevate the standard for science-backed skincare and invest in technologies that support skin wellness at the molecular level,” said Sylwia Pawlaczyk, COO of AV Laboratories.
“I’m excited to join the Scientific Advisory Board at AV Laboratories at a time when the conversation around longevity and skin health is rapidly evolving. AVL’s commitment to rigorous science and meaningful innovation aligns deeply with my own philosophy of patient-first, evidence-based care. I look forward to contributing to the brand’s continued research and development efforts,” said Engelman.
AV Laboratories stated that its Scientific Advisory Board includes physicians and researchers who support the brand’s focus on clinically backed, biotechnology-driven skincare solutions.
For more information, visit www.avlaboratories.com.
Source: AV Laboratories
